271 related articles for article (PubMed ID: 24619302)
1. Assessment of circulating microRNAs in plasma of lung cancer patients.
Fortunato O; Boeri M; Verri C; Conte D; Mensah M; Suatoni P; Pastorino U; Sozzi G
Molecules; 2014 Mar; 19(3):3038-54. PubMed ID: 24619302
[TBL] [Abstract][Full Text] [Related]
2. Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.
Conte D; Verri C; Borzi C; Suatoni P; Pastorino U; Sozzi G; Fortunato O
BMC Genomics; 2015 Oct; 16():849. PubMed ID: 26493562
[TBL] [Abstract][Full Text] [Related]
3. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
5. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.
Mensah M; Borzi C; Verri C; Suatoni P; Conte D; Pastorino U; Orazio F; Sozzi G; Boeri M
J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155727
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.
Aushev VN; Zborovskaya IB; Laktionov KK; Girard N; Cros MP; Herceg Z; Krutovskikh V
PLoS One; 2013; 8(10):e78649. PubMed ID: 24130905
[TBL] [Abstract][Full Text] [Related]
9. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of circulating miRNA detection in lung cancer.
Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
[TBL] [Abstract][Full Text] [Related]
11. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
12. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
13. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study on circulating miRNAs in patients after lung cancer resection.
Leidinger P; Galata V; Backes C; Stähler C; Rheinheimer S; Huwer H; Meese E; Keller A
Oncotarget; 2015 Jun; 6(18):16674-85. PubMed ID: 26078336
[TBL] [Abstract][Full Text] [Related]
15. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
18. Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.
Powrózek T; Krawczyk P; Kowalski DM; Kuźnar-Kamińska B; Winiarczyk K; Olszyna-Serementa M; Batura-Gabryel H; Milanowski J
Tumour Biol; 2016 Feb; 37(2):2049-55. PubMed ID: 26341493
[TBL] [Abstract][Full Text] [Related]
19. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
20. Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals.
Zaporozhchenko IA; Morozkin ES; Ponomaryova AA; Rykova EY; Cherdyntseva NV; Zheravin AA; Pashkovskaya OA; Pokushalov EA; Vlassov VV; Laktionov PP
Sci Rep; 2018 Apr; 8(1):6348. PubMed ID: 29679068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
